Incyte Corp is a biopharmaceutical company focused on developing and commercializing treatments for cancer and autoimmune diseases. It is known for its flagship product, JAKAFI, used in treating various blood-related disorders, and has a diverse portfolio including therapies for leukemia, lymphoma, and skin diseases. Incyte is actively involved in research, with several products in clinical trials aiming to address unmet medical needs in oncology and inflammation. The company collaborates with other pharmaceutical entities to expand its reach and improve patient care globally. Headquartered in Wilmington, Delaware, Incyte continues to innovate in the healthcare space.